Cancer research
A new study has found that a proportion of men with low-risk prostate cancer, specifically grade group 1 (GG1), have a higher-risk disease than previously suggested by biopsy. The study, published in JAMA Oncology, used data from over 117,000 men with localized GG1 prostate cancer and found that 60%
Cancer research
The UK Parliament emphasizes the significance of research in tackling cancer, investing £1.6 billion per year through the National Institute for Health and Care Research (NIHR). Cancer research is a top priority, with £133 million allocated in 2023-2024. The TRANSFORM trial is a notable example of this investment, aiming
Cancer
Olympic cycling legend Chris Hoy, 49, has been diagnosed with incurable Stage 4 prostate cancer, with a prognosis of two to four years to live. Despite this devastating news, Hoy has remained optimistic, learning to appreciate life and find positivity in the face of adversity. Since speaking out about his
Cancer
Researchers at Yale University School of Medicine have investigated the diagnostic outcomes of MRI-ultrasound fusion targeted biopsy in detecting clinically significant prostate cancer. The study aimed to evaluate the effectiveness of using microUS technology and conventional ultrasound in detecting cancers using targeted biopsy. The researchers analyzed a matched sample of
Cancer
A 75-year-old retired primary school teacher, Jean Quinn, has completed a 373-mile bike ride from Colchester to Devon for Prostate Cancer UK. The ride, which took place in late July, is a testament to Quinn's determination and love for cycling. As a volunteer with Sustrans, a charity that
Cancer
Ryne Sandberg, a legendary figure in Chicago Cubs history and a member of the Major League Baseball Hall of Fame, has passed away at the age of 65 following a battle with metastatic prostate cancer. Sandberg's journey with the disease was marked by periods of hope and then
Prostate cancer
A new treatment that leverages the body's immune system to combat prostate cancer has shown significant promise in early clinical trials. The innovative therapy, known as pasritamig, has demonstrated the ability to shrink tumors and achieve a median progression-free survival of nearly eight months in patients with advanced
Cancer
Toronto researchers, led by Gang Zheng, associate research director of the Princess Margaret Cancer Centre, University Health Network, and professor of medical biophysics at the University of Toronto's Temerty Faculty of Medicine, have received Health Canada approval to conduct clinical trials for a novel class of nanoparticles called
Cancer research
Researchers from Wroclaw Medical University in Poland have presented data on the increasing incidence of genitourinary cancers, including prostate cancer, kidney cancer, bladder cancer, and testicular cancer. The team has highlighted the importance of tumor markers in the diagnosis and treatment of these diseases. According to the research, tumor markers
Cancer research
A recent study has shed new light on the effect of radiotherapy on prostate cancer patients, particularly in regards to dose-response mapping (DRM) and its impact on identifying high-risk subregions in the bladder and rectum. Key Takeaways: * The study analyzed 1808 datasets from prostate cancer patients undergoing radiotherapy, with 589
Cancer research
A new study conducted by the Global Robotics Institute has shed light on the varying outcomes of ductal adenocarcinoma (DAC) and acinar adenocarcinoma (AAC) in patients undergoing robotic-assisted radical prostatectomy (RARP). The research, published in the International Urology and Nephrology journal, found that DAC was associated with higher extracapsular extension
Cancer research
Researchers at the Mayo Clinic have investigated the effect of salvage radiation therapy (SRT) on the long-term natural history of biochemical recurrence (BCR) in patients with prostate cancer after radical prostatectomy. The study examined the outcomes of 6881 patients with BCR, with 2109 receiving SRT and 4772 undergoing observation alone.
